Strs Ohio Tarsus Pharmaceuticals, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 02, 2023	BUY	$11.92 - $16.27 $45,296 - $61,826	3,800 New	3,800 $47,000
Q1 2023 Apr 27, 2023	SELL	$11.92 - $16.27 $230,056 - $314,011	-19,300 Reduced 83.55%	3,800 $47,000
Q4 2022 Jan 26, 2023	SELL	$14.12 - $18.72 $69,188 - $91,728	-4,900 Reduced 17.5%	23,100 $338,000
Q2 2022 Jul 25, 2022	BUY	$11.08 - $19.08 $286,972 - $494,171	25,900 Added 1233.33%	28,000 $408,000
Q2 2021 Jul 26, 2021	BUY	$27.16 - $38.59 $16,296 - $23,154	600 Added 40.0%	2,100 $60,000
Q4 2020 Jan 25, 2021	BUY	$19.17 - $49.62 $28,755 - $74,430	1,500 New	1,500 $61,000

170

43.3M

484K

4.1K

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.4B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.